SCHEMBL21920995

SCHEMBL21920995

CC/N=C(\C=C(/C)C(=O)O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.45
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ AKR1C3 P42330 1/20 0.43
▸ PARP1 P09874 1/20 0.39
▸ PARP15 Q460N3 1/20 0.39
▸ PARP10 Q53GL7 1/20 0.39
▸ CES2 O00748 3/20 0.39
▸ CES1 P23141 3/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ PGR P06401 2/20 0.38
▸ ESR1 P03372 2/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5032771 0.78 NFE2L2 (0.45) CYP1A2CYP2D6HSD17B10CES2CES1
SCHEMBL5566136 0.75 AKR1C3 (0.54) CYP2C9AKR1C3PARP1PARP15PARP10
SCHEMBL19853768 0.74 ATM (0.41) CYP1A2CYP2D6HSD17B10CES2CES1
SCHEMBL20674777 0.74 AKT1 (0.42) CYP2C9CYP1A2CYP2D6HSD17B10CES2
SCHEMBL2791186 0.74 NFE2L2 (0.59) CYP2C9CYP1A2CYP2D6HSD17B10AKR1C3
SCHEMBL8104632 0.74 NFE2L2 (0.59) CYP2C9CYP1A2CYP2D6HSD17B10AKR1C3
SCHEMBL22649497 0.73 CES2 (0.49) CYP1A2CYP2D6HSD17B10CES2CES1
SCHEMBL3386465 0.72 AKR1C3 (0.50) CYP2C9AKR1C3PARP1PARP15PARP10
SCHEMBL12657652 0.72 AKR1C3 (0.50) CYP2C9AKR1C3PARP1PARP15PARP10
SCHEMBL20860670 0.71 CYP2C9 (0.34) CYP2C9AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632899-A1 ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS RaQualia Pharma Inc. (JP) 2020-04-08 — — EP disclosed
Send feedback